Abstract: The present invention related to an electrochemical cell comprising an anode of a Group IA metal and a cathode of a composite material prepared from a combination of vanadium oxide and either a copper or a silver oxide and the other of a copper or a silver nitrate. The cathode material of the present invention provides an increased gravimetric energy density over the cathode active materials of the prior art along with an increased pulse voltage delivery capacity. This makes the cathode material of the present invention particularly useful for implantable medical applications.

Abstract: The present invention related to an electrochemical cell comprising an anode of a Group IA metal and a cathode of a composite material prepared from a combination of vanadium oxide and either a copper or a silver oxide and the other of a copper or a silver nitrate. The cathode material of the present invention provides an increased gravimetric energy density over the cathode active materials of the prior art along with an increased pulse voltage delivery capacity. This makes the cathode material of the present invention particularly useful for implantable medical applications.

Abstract: An electrochemical cell comprising a lithium anode, a cathode comprising a blank cut from a free-standing sheet of a silver vanadium oxide mixture contacted to a current collector. The active material has having a relatively lower surface area and an electrolyte activating the anode and the cathode is described. By optimizing the cathode active material surface area in a SVO-containing cell, the magnitude of the passivating film growth at the solid-electrolyte interphase (SEI) and its relative impermeability to lithium ion diffusion is reduced. Therefore, by using a cathode of an active material, in a range of from about 0.2 m2/gram to about 2.6 m2/gram, and preferably from about 1.6 m2/gram to about 2.4 m2/gram, it is possible to eliminate or significantly reduce undesirable irreversible Rdc growth and voltage delay in the cell and to extend its useful life in an implantable medical device.

Abstract: An electrochemical cell comprising a lithium anode, a cathode comprising a blank cut from a free-standing sheet of a silver vanadium oxide mixture contacted to a current collector. The active material has having a relatively lower surface area and an electrolyte activating the anode and the cathode is described. By optimizing the cathode active material surface area in a SVO-containing cell, the magnitude of the passivating film growth at the solid-electrolyte interphase (SEI) and its relative impermeability to lithium ion diffusion is reduced. Therefore, by using a cathode of an active material in a range of from about 0.2 m2/gram to about 2.6 m2/gram, and preferably from about 1.6 m2/gram to about 2.4 m2/gram, it is possible to eliminate or significantly reduce undesirable irreversible Rdc growth and voltage delay in the cell and to extend its useful life in an implantable medical device.

Abstract: A method for determining whether a cell will experience unacceptable voltage delay later in its discharge life before it is incorporated into a device as its power source is described. As is standard practice, the cell is first subjected to a constant resistance load discharge followed by extended elevated temperature storage and an acceptance pulse discharge. This typically depletes the cell of about 1% to 3% of its theoretical discharge capacity. According to the present invention, the cell is again stored at an elevated temperature for an extended period followed by a second pulse discharge. This second pulse discharge is to ferret out any cell that may end up experiencing unacceptable voltage delay later in its discharge life.